Disc Medicine, Inc.
IRON
$92.38
$2.662.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -181.11M | -145.39M | -116.49M | -109.36M | -103.48M |
| Total Depreciation and Amortization | 201.00K | 125.00K | 150.00K | 156.00K | 172.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.61M | 15.33M | 12.01M | 12.04M | 10.21M |
| Change in Net Operating Assets | -5.37M | -4.29M | 2.63M | 3.23M | 8.95M |
| Cash from Operations | -164.67M | -134.23M | -101.70M | -93.93M | -84.15M |
| Capital Expenditure | -1.36M | -1.33M | -1.29M | -505.00K | -59.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -171.47M | -292.13M | -563.61M | -291.83M | -290.85M |
| Cash from Investing | -172.83M | -293.46M | -564.90M | -292.33M | -290.91M |
| Total Debt Issued | 28.99M | 28.99M | 28.99M | 28.99M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 248.55M | 237.39M | 409.68M | 190.72M | 197.28M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 7.99M | 7.99M | 7.99M | -1.39M | 0.00 |
| Cash from Financing | 285.53M | 274.37M | 446.67M | 218.31M | 197.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -51.97M | -153.32M | -219.94M | -167.94M | -177.78M |